333 related articles for article (PubMed ID: 26954873)
1. Successful Isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome.
Ahmed Y; Delaney S; Markarian A
Am J Otolaryngol; 2016; 37(2):152-5. PubMed ID: 26954873
[TBL] [Abstract][Full Text] [Related]
2. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
3. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
[TBL] [Abstract][Full Text] [Related]
4. The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
Chitasombat MN; Kontoyiannis DP
Expert Opin Pharmacother; 2015; 16(10):1543-58. PubMed ID: 26100603
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal rhinosinusitis in Maharaj Nakorn Chiang Mai Hospital.
Roongrotwattanasiri K; Fooanant S; Naksane L
J Med Assoc Thai; 2007 Nov; 90(11):2524-8. PubMed ID: 18181345
[TBL] [Abstract][Full Text] [Related]
6. Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
Ananda-Rajah MR; Kontoyiannis D
Future Microbiol; 2015; 10(5):693-708. PubMed ID: 26000646
[TBL] [Abstract][Full Text] [Related]
7. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Perfect JR; Cornely OA; Heep M; Ostrosky-Zeichner L; Mullane KM; Maher R; Croos-Dabrera R; Lademacher C; Engelhardt M; Chen C; Marty FM
Mycoses; 2018 Jul; 61(7):420-429. PubMed ID: 29570857
[TBL] [Abstract][Full Text] [Related]
8. Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.
Murrell D; Bossaer JB; Carico R; Harirforoosh S; Cluck D
Int J Pharm Pract; 2017 Feb; 25(1):18-30. PubMed ID: 27569742
[TBL] [Abstract][Full Text] [Related]
9. Fungus: a role in pathophysiology of chronic rhinosinusitis, disease modifier, a treatment target, or no role at all?
Fokkens WJ; Ebbens F; van Drunen CM
Immunol Allergy Clin North Am; 2009 Nov; 29(4):677-88. PubMed ID: 19879443
[TBL] [Abstract][Full Text] [Related]
10. Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
Shirley M; Scott LJ
Drugs; 2016 Nov; 76(17):1647-1657. PubMed ID: 27766566
[TBL] [Abstract][Full Text] [Related]
11. Part 2: mucormycosis: focus on therapy.
Lynch JP; Zhanel GG
Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
[TBL] [Abstract][Full Text] [Related]
12. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Pomorska A; Malecka A; Jaworski R; Radon-Proskura J; Hare RK; Nielsen HV; Andersen LO; Jensen HE; Arendrup MC; Irga-Jaworska N
Mycopathologia; 2019 Feb; 184(1):81-88. PubMed ID: 30039238
[TBL] [Abstract][Full Text] [Related]
13. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
Barg AA; Malkiel S; Bartuv M; Greenberg G; Toren A; Keller N
Pediatr Blood Cancer; 2018 Oct; 65(10):e27281. PubMed ID: 29932282
[TBL] [Abstract][Full Text] [Related]
15. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Miceli MH; Kauffman CA
Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of invasive fungal rhinosinusitis caused by Aspergillus and Mucorales].
He CY; Piao YS; Tian C; Li LL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):662-6. PubMed ID: 23302306
[TBL] [Abstract][Full Text] [Related]
17. Acute invasive fungal rhinosinusitis: our experience with 18 cases.
Bakhshaee M; Bojdi A; Allahyari A; Majidi MR; Tavakol S; Najafzadeh MJ; Asghari M
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4281-4287. PubMed ID: 27272179
[TBL] [Abstract][Full Text] [Related]
18. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Rybak JM; Marx KR; Nishimoto AT; Rogers PD
Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
[TBL] [Abstract][Full Text] [Related]
19. Phoma and Acremonium invasive fungal rhinosinusitis in congenital acute lymphocytic leukemia and literature review.
Roehm CE; Salazar JC; Hagstrom N; Valdez TA
Int J Pediatr Otorhinolaryngol; 2012 Oct; 76(10):1387-91. PubMed ID: 22818128
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Marty FM; Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Oren I; Schmitt-Hoffmann AH; Giladi M; Rahav G; Perfect JR
Mycoses; 2018 Jul; 61(7):485-497. PubMed ID: 29611227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
